<--- Back to Details
First PageDocument Content
Applied ethics / Ethics / Design of experiments / Pharmacology / Research ethics / Declaration of Helsinki / Institutional review board / Placebo-controlled study / Nuremberg Code / Clinical research / Research / Medical ethics
Date: 2001-12-10 13:12:04
Applied ethics
Ethics
Design of experiments
Pharmacology
Research ethics
Declaration of Helsinki
Institutional review board
Placebo-controlled study
Nuremberg Code
Clinical research
Research
Medical ethics

Add to Reading List

Source URL: www.onk.ns.ac.rs

Download Document from Source Website

File Size: 62,92 KB

Share Document on Facebook

Similar Documents

Results of the Randomized, Double-Blind, Placebo-Controlled, Phase 3 Hercules Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura Marie Scully, Spero Cataland, Flora Peyvandi, Paul Coppo,

DocID: 1utac - View Document

Clin Exp Allergy 2002; 32:928±932 A double-blind, placebo-controlled study on the diagnostic accuracy of an electrodermal test in allergic subjects M. Semizzi, G. Senna*, M. Crivellaro*, G. Rapacioli{, G. Passalacqua{,

DocID: 1t7cl - View Document

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Niraparib Maintenance Treatment in Patients with HRD-Positive Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemothe

DocID: 1rDJY - View Document

Medicine / Alternative medicine / Pseudoscience / Health / Consumer fraud / Homeopathy / Placebo-controlled study / Sinusitis

Press release from the International Council for Homeopathy ICH is the international professional platform representing the interests of 32 national associations of professional homeopathy practitioners in 30 Countries

DocID: 1qj7u - View Document

Alcohols / Prostaglandins / Acetic acids / Treprostinil / Carboxylic acids / Orphan drugs / Pulmonary hypertension / Prostacyclin / Bosentan

TRIUMPH I study: Double Blind Placebo Controlled Clinical Investigation into the Efficacy and Tolerability of Inhaled Treprostinil Sodium in Patients with Severe Pulmonary Arterial Hypertension

DocID: 1oueC - View Document